Cannabis Consumers Have High Levels of Empathy
In a study, psychological assessments indicated that people who regularly use cannabis tend to have a greater understanding of the emotions of others.
Mycotoxins in Cannabis Products Are a Threat to Immunocompromised Patients, Say Researchers
Cannabis use, even for medical purposes, could make some people sick due to harmful fungi that contaminate the plants, according to the researchers.
A2LA Partners With National Industrial Hemp Council of America
The new program is recognized by the International Laboratory Accreditation Cooperation, the international organization for accreditation bodies.
Michigan Regulator Recalls Cannabis Edibles That Exceeded Allowable THC Levels
Regulators in Michigan have recalled a series of cannabis edibles due to their high THC levels and non-compliant packaging.
Kaycha Labs Partners With NIST
Kaycha Labs, a multi-state cannabis testing company, has partnered with the National Institute of Standards and Technology (NIST) in an initiative to help standardize the measurements used by cannabis labs.
Montana Cannabis Lab Closes Due to State-Software Concerns
The owners of a cannabis testing lab in Montana have shut the business down out of concern that a software, required by the state’s regulators, may be inadvertently approving un-tested cannabis.
Half of Maine’s Medical Cannabis May Contain Pesticides, Officials Say
Almost half of Maine’s medical cannabis products would fail the contaminant tests that the state’s recreational cannabis products are subjected to. That’s the conclusion of a study conducted by Maine’s own Office of Cannabis Policy (OCP).
California Cannabis Regulator Sends Warning Letter to Labs, Announcing Reference Lab Tests
In an email letter sent last week – seen by Analytical Cannabis – the Department of Cannabis Control (DCC) reminded licensed labs that they are “required to accurately report testing results for cannabis batches.”
Psilocybin Helps Treat Depression in Phase 2 Trial
The researchers say their findings add to the growing body of evidence that psilocybin can be used in a clinical setting to treat depression.
